IP Library Granted Patent US 8,933,240
Granted Patent B2
US 8,933,240 · App. 13/813,516 · Granted Jan 13, 2015

Synthesis for thiazolidinedione compounds

Inventors: Steven P. Tanis (Carlsbad, CA); Timothy Parker (Portage, MI); Robert C. Gadwood (Portage, MI); Gerald D. Artman, III (Schoolcraft, MI); James R. Zeller (Scottsdale, AZ)
Assignee: Metabolic Solutions Development Company, LLC
C07D277/34C07C309/65C07C309/66C07C309/73C07C251/48C07F9/145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,933,240
App. No.
13/813,516
Granted
Jan 13, 2015
Kind
B2
Abstract

The present invention provides novel methods for synthesizing PPARγ sparing compounds, e.g., thiazolidinediones, that are useful for preventing and/or treating metabolic disorders such as diabetes, obesity, hypertension, and inflammatory diseases.

Claims (81)

1. A method for preparing a compound of Formula I:

or a pharmaceutically acceptable salt thereof, wherein

Each of R 1 and R 2 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic or alkoxy is optionally substituted with 1-3 of halo;

comprising the step of:

reducing a compound of Formula 2A:

to form a compound of Formula 3A; and

converting the compound of Formula 3A to a compound of Formula I.

2. The method of claim 1 , further comprising converting a compound of Formula 4A

into a compound of Formula 2A.

3. The method of claim 2 , further comprising treating the compound of Formula 4A with a reagent comprising HONH 2 .HCl, HONH 2 , TMSNHOTMS, (H 2 NOH) 2 .H 2 SO 4 , or any combination thereof to generate the compound of Formula 2A.

4. The method of claim 2 , further comprising reacting a compound of Formula 5A

wherein X is a leaving group, with the compound of Formula 6A

to form a compound of Formula 4A.

5. The method of claim 4 , wherein X is a leaving group selected from —Br, —Cl, —I, —OMs, —OTs, —OTf, —OBs, —ONs, —O-tresylate, or —OPO(OR 4 ) 2 , wherein each R 4 is independently C 1-4 alkyl or two of R 4 together with the oxygen and phosphorous atoms to which they are attached form a 5-7 membered ring.

6. The method of claim 4 , wherein the compound of Formula 5A comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

7. The method of claim 4 , wherein the compound of Formula 5A comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo.

8. The method of claim 4 , wherein the compound of Formula 5A comprises

9. The method of claim 4 , further comprising halogenating a compound of Formula 7A

to form a compound of Formula 5A.

10. The method of claim 9 , wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

11. The method of claim 10 , wherein R 1 is C 1-6 alkoxy optionally substituted with 1-3 halo, and R 2 is —H.

12. The method of claim 4 , wherein X is selected from —Br and —Cl.

13. The method of claim 4 , further comprising reacting the compound

with the compound

under condensation conditions to form a compound of Formula 6A.

14. The method of claim 1 , wherein the compound of Formula 2A is reduced to a compound of Formula 3A in the presence of a reagent comprising NaBH 4 , LiBH 4 , KBH 4 , or any combination thereof and a catalyst comprising CoCl 2 .

15. The method of claim 1 , wherein the compound of Formula 3A is converted to a compound of Formula I in the presence of an aqueous acid.

16. The method of claim 15 , wherein the aqueous acid comprises aqueous HCl or aqueous H 2 SO 4 .

17. The method of claim 1 , further comprising reacting a compound of Formula 5B

wherein X is a leaving group, with a compound of Formula 6A

to form a compound of Formula 2A.

18. The method of claim 17 , further comprising converting a compound of Formula 5A

to form a compound of Formula 5B.

19. The method of claim 18 , wherein the compound of Formula 5A comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

20. The method of claim 19 , wherein the compound of Formula 5A comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo.

21. The method of claim 20 , wherein the compound of Formula 5A comprises

22. The method of claim 18 , further comprising halogenating a compound of Formula 7A

to form a compound of Formula 5A.

23. The method of claim 22 , wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

24. The method of claim 23 , wherein R 1 is selected from methoxy, ethoxy, or propoxy, any of which is optionally substituted with 1-3 halo.

25. The method of claim 17 , wherein X is selected from —Br and —Cl.

26. The method of claim 25 , further comprising reacting the compound

with the compound

under condensation conditions to form a compound of Formula 6A.

27. The method of claim 17 , wherein the compound of Formula 2A is reduced to a compound of Formula 3A in the presence of a reagent comprising NaBH 4 , LiBH 4 , KBH 4 , or any combination thereof and a catalyst comprising CoCl 2 .

28. The method of claim 27 , wherein the compound of Formula 3A is converted to a compound of Formula I in the presence of an aqueous acid.

29. The method of claim 28 , wherein the aqueous acid comprises aqueous HCl or aqueous H 2 SO 4 .

30. The method of claim 2 , further comprising reacting a compound of Formula 8A

with the compound

under condensation conditions to form a compound of Formula 4A.

31. The method of claim 30 , further comprising reacting a compound of Formula 5A

wherein X is a leaving group, with 4-hydroxybenzaldehyde to form a compound of Formula 8A.

32. The method of claim 31 , wherein the compound of Formula 5A comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

33. The method of claim 32 , wherein the compound of Formula 5A Comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo.

34. The method of claim 33 , wherein the compound of Formula 5A comprises

35. The method of claim 34 , further comprising halogenating a compound of Formula 7A

to form a compound of Formula 5A.

36. The method of claim 35 , wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

37. The method of claim 36 , wherein R 1 is selected from methoxy, ethoxy, or propoxy, any of which is optionally substituted with 1-3 halo.

38. The method of claim 31 , wherein X is selected from —Br and —Cl.

39. The method of claim 1 , further comprising reacting a compound of Formula 8B

with the compound

to generate the compound of Formula 2A.

40. The method of claim 39 , further comprising reacting a compound of Formula 5B

wherein X is a leaving group, with 4-hydroxybenzaldehyde to form a compound of Formula 8B.

41. The method of claim 40 , wherein the compound of Formula 5B comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

42. The method of claim 41 , wherein the compound of Formula 5B comprises

wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo.

43. The method of claim 41 , wherein the compound of Formula 5B comprises

44. The method of claim 40 , further comprising halogenating a compound of Formula 7B

to form a compound of Formula 5B.

45. The method of claim 44 , wherein R 1 is selected from a C 1-6 alkyl or C 1-6 alkoxy, either of which is optionally substituted with 1-3 halo, and R 2 is —H or halo.

46. The method of claim 45 , wherein R 1 is selected from methoxy, ethoxy, or propoxy, any of which is optionally substituted with 1-3 halo.

47. The method of claim 43 , wherein X is selected from —Br and —Cl.

Assignments (5)
CHANGE OF NAME Recorded May 12, 2017
From: OCTETA THERAPEUTICS, LLC
To: CIRIUS THERAPEUTICS, INC.
Reel/Frame 042457/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: OCTETA THERAPEUTICS, LLC
Reel/Frame 038996/0394 →
RELEASE OF SECURITY INTEREST Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY AGREEMENT Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2013
From: TANIS, STEVEN P.; PARKER, TIMOTHY; GADWOOD, ROBERT C.; ZELLER, JAMES R.; ARTMAN, GERALD D., III
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 030459/0400 →
Continuity (2)
Provisional Application 61372282 · Aug 10, 2010
Related Publication 20130204008A1 · Aug 8, 2013